slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 40,171-40,200
Pages 3,683
Rows per page 30
Component
40,171-40,200 of 110,471
22
Benson Hill | Results Presentation Deck | 30 slidesBenson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials2 hits
03
Includes company mission, business model summary, target market sizing, and key performance indicators.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 2 hits
12
Includes a spider plot for target lesion change and a Kaplan-Meier survival curve with a summary table.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet2 hits
16
Includes detailed footnotes for data sources and medical abbreviations.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet2 hits
28
The chart tracks % change in target lesions over time (weeks) for two specific patients.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap2 hits
31
The slide outlines patient enrollment targets and treatment protocols for specific refractory patient populations.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap2 hits
36
The slide outlines a dose-escalation study (3+3 design) leading to RP2D selection and subsequent expansion cohorts.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap2 hits
38
The slide uses a before-after-bridge style comparison between the problem (toxicity) and the solution (BA3182).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap2 hits
40
The slide uses a two-column layout to represent 1H and 2H of 2023.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap2 hits
04
Uses a comparative structure to contrast Sepsis vs Septic Shock, followed by impact metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
06
Uses a before-after-bridge framework to contrast current pain points with the proposed solution.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
07
The slide uses a two-column layout to contrast the hardware platform with the consumable cartridges.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
20
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
08
The slide details specific inclusion/exclusion criteria, including age, mutation status, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction2 hits
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
23
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
32
The slide uses a central human anatomical illustration to bridge the two distinct types of cancer models presented.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
34
Includes an in vitro cell viability dose-response curve and a pharmacokinetic (PK) model showing plasma concentration over time.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
12
Uses a plus sign to visually represent the synergy between the two entities.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Beat · ProblemLoop · Why Now2 hits
18
The slide uses a two-column layout comparing 'Growth Levers' (left) and 'Targeted Support' (right) with specific subsidiary examples.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 2 hits
19
The slide uses a two-column layout to contrast internal management empowerment with external 'preferred buyer' reputation.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 2 hits
19
The slide uses a combination of bar charts for revenue and a waterfall-style or negative-bar chart for EBITDA, highlighting margin percentages.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction2 hits
08
The slide uses a comparison to erectile dysfunction to frame the market opportunity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
11
The slide highlights clinical trial outcomes and regulatory next steps.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
15
Includes a quote from a Bayer executive regarding the collaboration.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
16
Includes clinical trial data table and regulatory roadmap steps.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
04
The slide uses a central logo as a focal point, flanked by quantitative metrics on the left and qualitative strategic pillars on the right, with an ESG footer.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations 2 hits
07
Hub-and-spoke diagram showing Deezer at the center of an ecosystem.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Problem2 hits
12
The slide uses waterfall-style bridges to show YoY growth across two different dimensions.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials2 hits
13
The slide uses a stacked bar chart for subscriber breakdown and a simple bar chart for ARPU growth.Deezer | Results Presentation Deck | 31 slides · Deezer
Conference presentation Investor relations Beat · Financials2 hits